Nivata IPO Market Data
Paras Healthcare
IPO GMP & Details
Check Paras Healthcare IPO GMP and its recorded history, price band, issue dates, total subscription, lot size and listing date. Unofficial GMP is not a listing forecast.
At a glance
Paras Healthcare IPO details
Unofficial market context
Paras Healthcare IPO GMP trend
The chart shows recent GMP movement over time. GMP is unofficial and should not be treated as a listing-price forecast or recommendation.
Latest chart observation+₹85
Change across recorded history+₹2
Recorded observations8
Current GMP reference price₹778
+₹120+₹83
15 Oct15 Oct
| Observation | GMP | Change | Reference price |
|---|---|---|---|
| 15 Oct 2026, 11:26 PM | +₹85 | −₹30 | ₹778 |
| 15 Oct 2026, 8:26 PM | +₹115 | ₹0 | ₹808 |
| 15 Oct 2026, 5:24 PM | +₹115 | +₹4 | ₹808 |
| 15 Oct 2026, 2:26 PM | +₹111 | −₹9 | ₹804 |
| 15 Oct 2026, 11:27 AM | +₹120 | +₹37 | ₹813 |
| 15 Oct 2026, 8:24 AM | +₹83 | ₹0 | — |
| 15 Oct 2026, 5:26 AM | +₹83 | ₹0 | — |
| 15 Oct 2026, 2:25 AM | +₹83 | — | — |
Issue schedule & market details
Paras Healthcare IPO key data
These are structured market-data fields. Missing values are left blank rather than estimated.
Issue typeMainboard
Price band₹660 – ₹693
Issue price₹693
Issue size₹1,450.00 Cr
Open date21 Oct 2026
Close date23 Oct 2026
Listing date28 Oct 2026
Current GMP+₹85
GMP reference price₹778
Quick facts
Paras Healthcare IPO FAQs
When does the Paras Healthcare IPO open and close?
The opening date is 21 Oct 2026. The closing date is 23 Oct 2026.
When is the Paras Healthcare IPO listing date?
The currently recorded listing date is 28 Oct 2026. The timetable can change if the issue schedule is revised.
What is the Paras Healthcare IPO price band?
The currently recorded price band is ₹660 – ₹693.
What is the Paras Healthcare IPO GMP?
The latest GMP recorded by Nivata is +₹85. GMP is unofficial market information and is not a listing-price forecast.
This page contains factual IPO schedule, pricing, subscription, listing and GMP information. It does not contain an IPO research article and does not provide a recommendation, rating, target price, valuation conclusion, expected return, listing forecast, allotment probability or a view on whether to participate in the issue.